Modulating α-synuclein clearance: a comparison of high-frequency and direct current stimulation in preclinical models of Parkinson's disease
Brain Communications · 2026-07-01 · 8 (4)
DOI: 10.1093/braincomms/fcag230 ↗At a glance
Leserbrief in Brain Communications, published online on 2026-06-23. Written by Minesh Kapadia and 2 co-authors. Institution: Krembil Research Institute, University Health Network, Toronto Western Hospital, Toronto, ON M5T 0S8, Canada. 10 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Není k dispozici žádný abstrakt.
Authors and institutions
- Krembil Research Institute, University Health Network, Toronto Western Hospital, Toronto, ON M5T 0S8, Canada.
- Division of Neurology, Department of Medicine, University of Toronto, Toronto, ON M5T 2S8, Canada.
- Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON M5T 2S8, Canada.
- Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON M5T 2S8, Canada.
- Center for Advancing Neurotechnological Innovation to Application (CRANIA), Toronto, ON M5T 2S8, Canada.
ORCID profiles: Minesh Kapadia
Cite
APA
Kapadia, M., Kalia, L. V., & Kalia, S. K. (2026). Modulating α-synuclein clearance: a comparison of high-frequency and direct current stimulation in preclinical models of Parkinson's disease. Brain Communications, 8(4). https://doi.org/10.1093/braincomms/fcag230
Vancouver
Kapadia M, Kalia LV, Kalia SK. Modulating α-synuclein clearance: a comparison of high-frequency and direct current stimulation in preclinical models of Parkinson's disease. Brain Communications. 2026;8(4). doi:10.1093/braincomms/fcag230
BibTeX
@article{Kapadia2026,
author = {Kapadia, Minesh and Kalia, Lorraine V and Kalia, Suneil K},
title = {Modulating α-synuclein clearance: a comparison of high-frequency and direct current stimulation in preclinical models of Parkinson's disease},
journal = {Brain Communications},
year = {2026},
volume = {8},
number = {4},
doi = {10.1093/braincomms/fcag230}
}
EUVIMED